Trial intelligence / Profile preview

Bioavailability of Clormadinone/Ethinyl Estradiol Tablets

NCT04713904Phase 1Completed

Sponsor
Laboratorios Andromaco S.A.
Start
Jan 2021
Primary completion
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of chlormadinone and ethinyl estradiol in contraception (2 arms), sponsored by Laboratorios Andromaco S.A. Primary endpoints: Area under the plasma concentration-time curve from time zero to 72 hours, Area under the plasma concentration-time curve from time zero to time t at 72 hours and 1 more. Started Jan 2021; status: completed.

02

Drugs

chlormadinoneethinyl estradiol
03

Conditions

contraception

Beyond the preview

Go deeper on NCT04713904.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04713904.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call